Answers are grounded in this paper and cite their sources.
The December edition of the ESHRE Journal Cub discussed a recent article by Tan et al. (2022) describing the use of metabolic imaging to detect aneuploidy non-invasively in mouse embryos. A strong body of evidence supports that embryonic aneuploidy increases the risk of pregnancy loss (Lee and Kiessling, 2017). The current method to detect aneuploidy, pre-implantation genetic testing for aneuploidy (PGT-A) through trophectoderm biopsy, is profoundly invasive and its widespread use and efficacy have been a source of debate. Thus, novel aneuploidy detection tools, especially those of non-invasive nature, may provide great clinical value. The article by Tan et al. (2022) is a fine example of interdisciplinary and innovative research approaches aimed to improve current ART processes. The authors of the paper measured autofluorescence of metabolic compounds (NADH and FADH) in human fibroblasts and in the inner cell mass (ICM) of mouse blastocysts using hyperspectral microscopy, showing that hyperspectral imaging, coupled with mathematical modelling, is able to detect aneuploidy. Journal Club participants, together with experts Antonio Capalbo and Roger Sturmey and authors of Tan et al. (2022), discussed the article’s study design, its potential for human research and the challenges of such innovations within IVF settings. The Twitter discussion generated over 600k impressions over a 24-h period.
No takes yet. Share an insight, caveat, or question.
Ammar et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: